Dianthus Therapeutics, Inc. /DE/
DNTH$651M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaNEW YORK78 employees
Drugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Jun 30, 2026
15wMarket Overview
Stock performance and key metrics
DNTH News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
DNTH103 | Phase 3 | Myasthenia Gravis, Generalized | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply